Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-26-012216
Filing Date
2026-03-23
Accepted
2026-03-23 18:52:30
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8289
2 EX-99.1 ex99-1.htm EX-99.1 12652
  Complete submission text file 0001493152-26-012216.txt   22834
Mailing Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108
Business Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

EIN.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA L3 Israel 7403648
Business Address 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA L3 Israel 7403648 97289313433
Sol-Gel Technologies Ltd. (Subject) CIK: 0001684693 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90328 | Film No.: 26783744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)